• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Shepard William R bought $325,798 worth of Common Stock Class A (1,429 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

    1/17/25 12:12:49 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    SHEPARD WILLIAM R

    (Last) (First) (Middle)

    (Street)
    20 S. WACKER DR IL 60606

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CME GROUP INC. [ CME ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    01/16/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock Class A 01/16/2025 P 1,368.84(1) A $227.96 256,805.15 I by Trust
    Common Stock Class A 01/16/2025 P 60.35(1) A $227.96 2,432.19 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding.
    Remarks:
    By: Jenelle Chalmers For: William R. Shepard 01/17/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CME alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    6/21/2024$206.00 → $187.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Carey Charles P sold $132,676 worth of Common Stock Class A (500 units at $265.35) (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/11/25 9:10:21 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Kaye Daniel G sold $141,210 worth of Common Stock Class A (500 units at $282.42), decreasing direct ownership by 12% to 3,668 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      5/23/25 12:20:33 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Sr MD General Counsel Marcus Jonathan L sold $108,225 worth of Common Stock Class A (390 units at $277.50), decreasing direct ownership by 5% to 6,708 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      5/21/25 1:43:54 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shepard William R bought $71,995 worth of Common Stock Class A (274 units at $262.62), increasing direct ownership by 0.48% to 2,443 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 7:19:14 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: Director Shepard William R bought $324,198 worth of Common Stock Class A (1,422 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4/A - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 6:55:07 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Shepard William R bought $325,798 worth of Common Stock Class A (1,429 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      1/17/25 12:12:49 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance